APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DNA and Gene Cloning Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA and Gene Cloning Services Market Outlook and Growth Opportunities 2026

Report ID 17412075042 January 2026197 pages

Choose your research edition.

Industry ResearchDNA and Gene Cloning Services Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA and Gene Cloning Services Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal DNA and Gene Cloning Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA and Gene Cloning Services Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA and Gene Cloning Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global DNA and Gene Cloning Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA and Gene Cloning Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA and Gene Cloning Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA and Gene Cloning Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA and Gene Cloning Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA and Gene Cloning Services market include Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome and Sino Biological, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global DNA and Gene Cloning Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA and Gene Cloning Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA and Gene Cloning Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA and Gene Cloning Services market.

DNA and Gene Cloning Services Segment by Company

Aragen Life Sciences

Bio-Techne

Charles River Laboratories

Curia

Eurofins

GenScript

Integrated DNA Technologies

MedGenome

Sino Biological

Syngene

Twist Bioscience

DNA and Gene Cloning Services Segment by Type

Gene Synthesis

Custom Cloning

Sub-cloning

Others

DNA and Gene Cloning Services Segment by Application

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Others

DNA and Gene Cloning Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA and Gene Cloning Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA and Gene Cloning Services key companies, revenue, market share, and recent developments.

3. To split the DNA and Gene Cloning Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA and Gene Cloning Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA and Gene Cloning Services significant trends, drivers, influence factors in global and regions.

6. To analyze DNA and Gene Cloning Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA and Gene Cloning Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA and Gene Cloning Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA and Gene Cloning Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA and Gene Cloning Services industry.

Chapter 3: Detailed analysis of DNA and Gene Cloning Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA and Gene Cloning Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA and Gene Cloning Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA and Gene Cloning Services Industry Trends Table 2. DNA and Gene Cloning Services Industry Drivers Table 3. DNA and Gene Cloning Services Industry Opportunities and Challenges Table 4. DNA and Gene Cloning Services Industry Restraints Table 5. Global DNA and Gene Cloning Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA and Gene Cloning Services Revenue Share by Company (2021-2026) Table 7. Global DNA and Gene Cloning Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA and Gene Cloning Services Key Company Manufacturing Base & Headquarters Table 9. Global DNA and Gene Cloning Services Company, Product Type & Application Table 10. Global DNA and Gene Cloning Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA and Gene Cloning Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Synthesis Table 15. Significant Companies of Custom Cloning Table 16. Significant Companies of Sub-cloning Table 17. Significant Companies of Others Table 18. Global DNA and Gene Cloning Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global DNA and Gene Cloning Services Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global DNA and Gene Cloning Services Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global DNA and Gene Cloning Services Sales Value Share by Type (2021-2026) Table 22. Global DNA and Gene Cloning Services Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Academic & Research Institutes Table 24. Significant Companies of Pharmaceutical & Biotechnology Companies Table 25. Significant Companies of Others Table 26. Global DNA and Gene Cloning Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global DNA and Gene Cloning Services Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global DNA and Gene Cloning Services Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global DNA and Gene Cloning Services Sales Value Share by Application (2021-2026) Table 30. Global DNA and Gene Cloning Services Sales Value Share by Application (2027-2032) Table 31. Global DNA and Gene Cloning Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global DNA and Gene Cloning Services Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global DNA and Gene Cloning Services Sales Value Share by Region (2021-2026) Table 34. Global DNA and Gene Cloning Services Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global DNA and Gene Cloning Services Sales Value Share by Region (2027-2032) Table 36. Global DNA and Gene Cloning Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global DNA and Gene Cloning Services Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global DNA and Gene Cloning Services Sales Value Market Share by Country (2021-2026) Table 39. Global DNA and Gene Cloning Services Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global DNA and Gene Cloning Services Sales Value Market Share by Country (2027-2032) Table 41. Aragen Life Sciences Company Information Table 42. Aragen Life Sciences Business Overview Table 43. Aragen Life Sciences DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Aragen Life Sciences DNA and Gene Cloning Services Product Portfolio Table 45. Aragen Life Sciences Recent Development Table 46. Bio-Techne Company Information Table 47. Bio-Techne Business Overview Table 48. Bio-Techne DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Bio-Techne DNA and Gene Cloning Services Product Portfolio Table 50. Bio-Techne Recent Development Table 51. Charles River Laboratories Company Information Table 52. Charles River Laboratories Business Overview Table 53. Charles River Laboratories DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Charles River Laboratories DNA and Gene Cloning Services Product Portfolio Table 55. Charles River Laboratories Recent Development Table 56. Curia Company Information Table 57. Curia Business Overview Table 58. Curia DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Curia DNA and Gene Cloning Services Product Portfolio Table 60. Curia Recent Development Table 61. Eurofins Company Information Table 62. Eurofins Business Overview Table 63. Eurofins DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Eurofins DNA and Gene Cloning Services Product Portfolio Table 65. Eurofins Recent Development Table 66. GenScript Company Information Table 67. GenScript Business Overview Table 68. GenScript DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GenScript DNA and Gene Cloning Services Product Portfolio Table 70. GenScript Recent Development Table 71. Integrated DNA Technologies Company Information Table 72. Integrated DNA Technologies Business Overview Table 73. Integrated DNA Technologies DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Integrated DNA Technologies DNA and Gene Cloning Services Product Portfolio Table 75. Integrated DNA Technologies Recent Development Table 76. MedGenome Company Information Table 77. MedGenome Business Overview Table 78. MedGenome DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. MedGenome DNA and Gene Cloning Services Product Portfolio Table 80. MedGenome Recent Development Table 81. Sino Biological Company Information Table 82. Sino Biological Business Overview Table 83. Sino Biological DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sino Biological DNA and Gene Cloning Services Product Portfolio Table 85. Sino Biological Recent Development Table 86. Syngene Company Information Table 87. Syngene Business Overview Table 88. Syngene DNA and Gene Cloning Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Syngene DNA and Gene Cloning Services Product Portfolio Table 90. Syngene Recent Development Table 91. Twist Bioscience Company Information Table 92. Twist Bioscience Business Overview Table 93. Twist Bioscience DNA and Gene Cloning Services Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Twist Bioscience DNA and Gene Cloning Services Product Portfolio Table 95. Twist Bioscience Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. DNA and Gene Cloning Services Product Image Figure 2. Global DNA and Gene Cloning Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA and Gene Cloning Services Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA and Gene Cloning Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Synthesis Image Figure 8. Custom Cloning Image Figure 9. Sub-cloning Image Figure 10. Others Image Figure 11. Global DNA and Gene Cloning Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global DNA and Gene Cloning Services Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global DNA and Gene Cloning Services Sales Value Share by Type (2021-2032) Figure 14. Academic & Research Institutes Image Figure 15. Pharmaceutical & Biotechnology Companies Image Figure 16. Others Image Figure 17. Global DNA and Gene Cloning Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global DNA and Gene Cloning Services Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global DNA and Gene Cloning Services Sales Value Share by Application (2021-2032) Figure 20. Global DNA and Gene Cloning Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global DNA and Gene Cloning Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America DNA and Gene Cloning Services Sales Value (2021-2032) & (US$ Million) Figure 23. North America DNA and Gene Cloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe DNA and Gene Cloning Services Sales Value (2021-2032) & (US$ Million) Figure 25. Europe DNA and Gene Cloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific DNA and Gene Cloning Services Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific DNA and Gene Cloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America DNA and Gene Cloning Services Sales Value (2021-2032) & (US$ Million) Figure 29. South America DNA and Gene Cloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa DNA and Gene Cloning Services Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa DNA and Gene Cloning Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Synthesis
  • Custom Cloning
  • Sub-cloning
  • Others
Applications
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
Companies covered
  • Aragen Life Sciences
  • Bio-Techne
  • Charles River Laboratories
  • Curia
  • Eurofins
  • GenScript
  • Integrated DNA Technologies
  • MedGenome
  • Sino Biological
  • Syngene
  • Twist Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA and Gene Cloning Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA and Gene Cloning Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA and Gene Cloning Services Market Dynamics
  1. 2.1 DNA and Gene Cloning Services Industry Trends
  2. 2.2 DNA and Gene Cloning Services Industry Drivers
  3. 2.3 DNA and Gene Cloning Services Industry Opportunities and Challenges
  4. 2.4 DNA and Gene Cloning Services Industry Restraints
3 DNA and Gene Cloning Services Market by Company
  1. 3.1 Global DNA and Gene Cloning Services Company Revenue Ranking in 2025
  2. 3.2 Global DNA and Gene Cloning Services Revenue by Company (2021-2026)
  3. 3.3 Global DNA and Gene Cloning Services Company Ranking (2024-2026)
  4. 3.4 Global DNA and Gene Cloning Services Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA and Gene Cloning Services Company Product Type and Application
  6. 3.6 Global DNA and Gene Cloning Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA and Gene Cloning Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA and Gene Cloning Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA and Gene Cloning Services Market by Type
  1. 4.1 DNA and Gene Cloning Services Type Introduction
  2. 4.1.1 Gene Synthesis
  3. 4.1.2 Custom Cloning
  4. 4.1.3 Sub-cloning
  5. 4.1.4 Others
  6. 4.2 Global DNA and Gene Cloning Services Sales Value by Type
  7. 4.2.1 Global DNA and Gene Cloning Services Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global DNA and Gene Cloning Services Sales Value by Type (2021-2032)
  9. 4.2.3 Global DNA and Gene Cloning Services Sales Value Share by Type (2021-2032)
5 DNA and Gene Cloning Services Market by Application
  1. 5.1 DNA and Gene Cloning Services Application Introduction
  2. 5.1.1 Academic & Research Institutes
  3. 5.1.2 Pharmaceutical & Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global DNA and Gene Cloning Services Sales Value by Application
  6. 5.2.1 Global DNA and Gene Cloning Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global DNA and Gene Cloning Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global DNA and Gene Cloning Services Sales Value Share by Application (2021-2032)
6 DNA and Gene Cloning Services Regional Value Analysis
  1. 6.1 Global DNA and Gene Cloning Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA and Gene Cloning Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA and Gene Cloning Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA and Gene Cloning Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA and Gene Cloning Services Sales Value (2021-2032)
  7. 6.3.2 North America DNA and Gene Cloning Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA and Gene Cloning Services Sales Value (2021-2032)
  10. 6.4.2 Europe DNA and Gene Cloning Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA and Gene Cloning Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA and Gene Cloning Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA and Gene Cloning Services Sales Value (2021-2032)
  16. 6.6.2 South America DNA and Gene Cloning Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA and Gene Cloning Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA and Gene Cloning Services Sales Value Share by Country, 2025 VS 2032
7 DNA and Gene Cloning Services Country-level Value Analysis
  1. 7.1 Global DNA and Gene Cloning Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA and Gene Cloning Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA and Gene Cloning Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA and Gene Cloning Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA and Gene Cloning Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA and Gene Cloning Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA and Gene Cloning Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aragen Life Sciences
  2. 8.1.1 Aragen Life Sciences Company Information
  3. 8.1.2 Aragen Life Sciences Business Overview
  4. 8.1.3 Aragen Life Sciences DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aragen Life Sciences DNA and Gene Cloning Services Product Portfolio
  6. 8.1.5 Aragen Life Sciences Recent Developments
  7. 8.2 Bio-Techne
  8. 8.2.1 Bio-Techne Company Information
  9. 8.2.2 Bio-Techne Business Overview
  10. 8.2.3 Bio-Techne DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bio-Techne DNA and Gene Cloning Services Product Portfolio
  12. 8.2.5 Bio-Techne Recent Developments
  13. 8.3 Charles River Laboratories
  14. 8.3.1 Charles River Laboratories Company Information
  15. 8.3.2 Charles River Laboratories Business Overview
  16. 8.3.3 Charles River Laboratories DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Charles River Laboratories DNA and Gene Cloning Services Product Portfolio
  18. 8.3.5 Charles River Laboratories Recent Developments
  19. 8.4 Curia
  20. 8.4.1 Curia Company Information
  21. 8.4.2 Curia Business Overview
  22. 8.4.3 Curia DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Curia DNA and Gene Cloning Services Product Portfolio
  24. 8.4.5 Curia Recent Developments
  25. 8.5 Eurofins
  26. 8.5.1 Eurofins Company Information
  27. 8.5.2 Eurofins Business Overview
  28. 8.5.3 Eurofins DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins DNA and Gene Cloning Services Product Portfolio
  30. 8.5.5 Eurofins Recent Developments
  31. 8.6 GenScript
  32. 8.6.1 GenScript Company Information
  33. 8.6.2 GenScript Business Overview
  34. 8.6.3 GenScript DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GenScript DNA and Gene Cloning Services Product Portfolio
  36. 8.6.5 GenScript Recent Developments
  37. 8.7 Integrated DNA Technologies
  38. 8.7.1 Integrated DNA Technologies Company Information
  39. 8.7.2 Integrated DNA Technologies Business Overview
  40. 8.7.3 Integrated DNA Technologies DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Integrated DNA Technologies DNA and Gene Cloning Services Product Portfolio
  42. 8.7.5 Integrated DNA Technologies Recent Developments
  43. 8.8 MedGenome
  44. 8.8.1 MedGenome Company Information
  45. 8.8.2 MedGenome Business Overview
  46. 8.8.3 MedGenome DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MedGenome DNA and Gene Cloning Services Product Portfolio
  48. 8.8.5 MedGenome Recent Developments
  49. 8.9 Sino Biological
  50. 8.9.1 Sino Biological Company Information
  51. 8.9.2 Sino Biological Business Overview
  52. 8.9.3 Sino Biological DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sino Biological DNA and Gene Cloning Services Product Portfolio
  54. 8.9.5 Sino Biological Recent Developments
  55. 8.10 Syngene
  56. 8.10.1 Syngene Company Information
  57. 8.10.2 Syngene Business Overview
  58. 8.10.3 Syngene DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Syngene DNA and Gene Cloning Services Product Portfolio
  60. 8.10.5 Syngene Recent Developments
  61. 8.11 Twist Bioscience
  62. 8.11.1 Twist Bioscience Company Information
  63. 8.11.2 Twist Bioscience Business Overview
  64. 8.11.3 Twist Bioscience DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Twist Bioscience DNA and Gene Cloning Services Product Portfolio
  66. 8.11.5 Twist Bioscience Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst